WOCKHARDT
Back to Cashflow Statement
|
WOCKHARDT Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹334 Cr | ₹-315 Cr | ₹-71 Cr | ₹-1,171 Cr | ₹-680 Cr |
What is the latest Cash Flow from Financing Activities ratio of WOCKHARDT ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹334 Cr |
Mar2023 | ₹-315 Cr |
Mar2022 | ₹-71 Cr |
Mar2021 | ₹-1,171 Cr |
Mar2020 | ₹-680 Cr |
How is Cash Flow from Financing Activities of WOCKHARDT Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹334 Cr | Positive | |
Mar2023 | ₹-315 Cr | Negative | |
Mar2022 | ₹-71 Cr | Negative | |
Mar2021 | ₹-1,171 Cr | Negative | |
Mar2020 | ₹-680 Cr | - |
Compare Cash Flow from Financing Activities of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹22,469.7 Cr | -9.2% | -1.6% | 221.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,003.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,939.0 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
CIPLA | ₹117,835.0 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,784.6 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹90,722.1 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | -9.2% |
-1.6% |
221.6% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses